SG11202002692XA - Azabicyclo and diazepine derivatives for treating ocular disorders - Google Patents
Azabicyclo and diazepine derivatives for treating ocular disordersInfo
- Publication number
- SG11202002692XA SG11202002692XA SG11202002692XA SG11202002692XA SG11202002692XA SG 11202002692X A SG11202002692X A SG 11202002692XA SG 11202002692X A SG11202002692X A SG 11202002692XA SG 11202002692X A SG11202002692X A SG 11202002692XA SG 11202002692X A SG11202002692X A SG 11202002692XA
- Authority
- SG
- Singapore
- Prior art keywords
- azabicyclo
- ocular disorders
- treating ocular
- diazepine derivatives
- diazepine
- Prior art date
Links
- 208000022873 Ocular disease Diseases 0.000 title 1
- 125000002576 diazepinyl group Chemical class N1N=C(C=CC=C1)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762581073P | 2017-11-03 | 2017-11-03 | |
| US201862749610P | 2018-10-23 | 2018-10-23 | |
| PCT/IB2018/058631 WO2019087146A1 (en) | 2017-11-03 | 2018-11-02 | Azabicyclo and diazepine derivatives for treating ocular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202002692XA true SG11202002692XA (en) | 2020-05-28 |
Family
ID=64267873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202002692XA SG11202002692XA (en) | 2017-11-03 | 2018-11-02 | Azabicyclo and diazepine derivatives for treating ocular disorders |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11306090B2 (https=) |
| EP (1) | EP3704117B1 (https=) |
| JP (3) | JP7065180B2 (https=) |
| KR (1) | KR20200083976A (https=) |
| CN (1) | CN111247147B (https=) |
| AU (3) | AU2018362010B2 (https=) |
| BR (1) | BR112020007744A2 (https=) |
| CA (2) | CA3076457C (https=) |
| ES (1) | ES3064457T3 (https=) |
| MX (2) | MX2020004580A (https=) |
| SG (1) | SG11202002692XA (https=) |
| TW (2) | TWI826399B (https=) |
| WO (2) | WO2019087149A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3128224A1 (en) * | 2019-02-01 | 2020-08-06 | Aerie Pharmaceuticals, Inc. | Compounds, compositions and methods for treatment of myopia |
| US12527739B2 (en) | 2022-09-11 | 2026-01-20 | Alcon Inc. | Aqueous pharmaceutical compositions comprising benzyl atropine and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1165037B (de) * | 1961-11-21 | 1964-03-12 | Dr. Schwarz Arzneimittelfabrik G.m.b.H., Monheim (RhId.) | Verfahren zur Herstellung von Estern quaternärer Atropiniumsalze. |
| GB994493A (en) * | 1963-02-06 | 1965-06-10 | Lepetit Spa | Tropine derivative |
| DE1670177A1 (de) | 1966-12-28 | 1970-11-12 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von neuen N-substituierten Noratropiniumsalzen |
| US5223528A (en) | 1986-03-17 | 1993-06-29 | University Of Florida | Anticholinergic compounds, composititons and methods of treatment |
| EP1397132A4 (en) * | 2001-05-25 | 2006-12-13 | Valley Forge Pharmaceuticals I | OPHTHALMIC PIRENZEPINE GEL |
| FR2834511B1 (fr) | 2002-01-07 | 2004-02-13 | Sanofi Synthelabo | Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique |
| CN1546490A (zh) | 2003-12-15 | 2004-11-17 | 常俊标 | 不对称双羟基托品类生物碱及其合成新方法和药物用途 |
| CN1283639C (zh) | 2004-06-08 | 2006-11-08 | 吴建梅 | 治疗近视眼的哌仑西平有机酸盐及其滴眼剂 |
| US20070254914A1 (en) * | 2006-05-01 | 2007-11-01 | Non-Profit Organization Chang Gung Memorial Hospital | Low-concentration atropine solution for preventing myopia progression and preparing method thereof |
| SI2657234T1 (sl) | 2010-12-22 | 2017-06-30 | Meiji Seika Pharma Co., Ltd. | Derivat optično-aktivnega diazabiciklooktana in metoda za njegovo izdelavo |
-
2018
- 2018-11-02 WO PCT/IB2018/058637 patent/WO2019087149A1/en not_active Ceased
- 2018-11-02 CA CA3076457A patent/CA3076457C/en active Active
- 2018-11-02 BR BR112020007744-5A patent/BR112020007744A2/pt unknown
- 2018-11-02 TW TW107138927A patent/TWI826399B/zh active
- 2018-11-02 CA CA3205816A patent/CA3205816A1/en active Pending
- 2018-11-02 KR KR1020207010292A patent/KR20200083976A/ko active Pending
- 2018-11-02 TW TW112150515A patent/TWI852865B/zh active
- 2018-11-02 AU AU2018362010A patent/AU2018362010B2/en active Active
- 2018-11-02 US US16/760,192 patent/US11306090B2/en active Active
- 2018-11-02 MX MX2020004580A patent/MX2020004580A/es unknown
- 2018-11-02 EP EP18800336.2A patent/EP3704117B1/en active Active
- 2018-11-02 SG SG11202002692XA patent/SG11202002692XA/en unknown
- 2018-11-02 WO PCT/IB2018/058631 patent/WO2019087146A1/en not_active Ceased
- 2018-11-02 JP JP2020520577A patent/JP7065180B2/ja active Active
- 2018-11-02 CN CN201880068606.5A patent/CN111247147B/zh active Active
- 2018-11-02 ES ES18800336T patent/ES3064457T3/es active Active
-
2020
- 2020-07-13 MX MX2022011310A patent/MX2022011310A/es unknown
-
2021
- 2021-07-16 AU AU2021205100A patent/AU2021205100B2/en active Active
-
2022
- 2022-03-21 US US17/699,606 patent/US11884666B2/en active Active
- 2022-04-25 JP JP2022071400A patent/JP2022101654A/ja active Pending
-
2023
- 2023-04-03 AU AU2023202036A patent/AU2023202036B2/en active Active
- 2023-11-30 US US18/524,807 patent/US12247028B2/en active Active
-
2024
- 2024-01-18 JP JP2024006023A patent/JP7777613B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249602A0 (en) | Methods and devices for the treatment of posterior ocular disorders | |
| HRP20210518T1 (hr) | Derivati 2,4-tiazolidindiona, namijenjeni liječenju poremećaja središnjeg živčanog sustava | |
| PL3618829T3 (pl) | Pochodne chinazolinopirydyny do leczenia zaburzeń związanych z nowotworem | |
| PL3634417T3 (pl) | Pochodne chinazolino-pirazolowe do leczenia chorób związanych z nowotworem | |
| IL248732A0 (en) | Compounds for the treatment of ophthalmological diseases and disorders | |
| GB201405232D0 (en) | Apparatus and methods for the treatment of ocular disorders | |
| IL267818A (en) | Methods for treating neurological disorders | |
| IL267229A (en) | Methods of treating ocular disorders | |
| ZA202002066B (en) | Compositions and methods for the treatment of eye disorders | |
| IL275654A (en) | Methods of treating CASTOR-related disorders | |
| IL268357A (en) | Photoreceptor cells for the treatment of retinal diseases | |
| IL275985A (en) | Preparations and methods for the treatment of retinal disorders | |
| SG11202002692XA (en) | Azabicyclo and diazepine derivatives for treating ocular disorders | |
| EP3200795A4 (en) | Use of agents for treating fat-related disorders | |
| ZA201806894B (en) | (+)-azasetron for use in the treatment of ear disorders | |
| HK40021785A (en) | Methods for treating complement-mediated diseases and disorders | |
| PT3442537T (pt) | (+)-azasetrom para utilização no tratamento de doenças do ouvido |